25 XP   0   0   10

Vitrolife AB
Buy, Hold or Sell?

Let's analyse Vitrolife together

PenkeI guess you are interested in Vitrolife AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vitrolife AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.

Quick analysis of Vitrolife (30 sec.)










What can you expect buying and holding a share of Vitrolife? (30 sec.)

How much money do you get?

How much money do you get?
kr0.15
When do you have the money?
1 year
How often do you get paid?
62.5%

What is your share worth?

Current worth
kr130.52
Expected worth in 1 year
kr142.99
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
kr14.13
Return On Investment
9.9%

For what price can you sell your share?

Current Price per Share
kr142.40
Expected price per share
kr127.30 - kr155.20
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Vitrolife (5 min.)




Live pricePrice per Share (EOD)

kr142.40

Intrinsic Value Per Share

kr36.46 - kr95.25

Total Value Per Share

kr166.98 - kr225.78

2. Growth of Vitrolife (5 min.)




Is Vitrolife growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5b$1.1b$343.2m22.4%

How much money is Vitrolife making?

Current yearPrevious yearGrowGrow %
Making money$8.7m$7.8m$882.2k10.1%
Net Profit Margin11.4%14.7%--

How much money comes from the company's main activities?

3. Financial Health of Vitrolife (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#24 / 356

Most Revenue
#80 / 356

Most Profit
#58 / 356
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Vitrolife? (5 min.)

Welcome investor! Vitrolife's management wants to use your money to grow the business. In return you get a share of Vitrolife.

What can you expect buying and holding a share of Vitrolife?

First you should know what it really means to hold a share of Vitrolife. And how you can make/lose money.

Speculation

The Price per Share of Vitrolife is kr142.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vitrolife.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vitrolife, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr130.52. Based on the TTM, the Book Value Change Per Share is kr3.12 per quarter. Based on the YOY, the Book Value Change Per Share is kr25.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.42 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vitrolife.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.070.0%0.060.0%0.060.0%0.060.0%0.050.0%
Usd Book Value Change Per Share0.440.3%0.280.2%2.311.6%0.550.4%0.290.2%
Usd Dividend Per Share0.080.1%0.040.0%0.040.0%0.030.0%0.030.0%
Usd Total Gains Per Share0.520.4%0.320.2%2.351.6%0.580.4%0.320.2%
Usd Price Per Share18.93-17.40-35.45-21.66-24.75-
Price to Earnings Ratio66.89-68.70-230.27-131.38-173.64-
Price-to-Total Gains Ratio36.41-64.50-54.75-128.54-660.20-
Price to Book Ratio1.60-1.53-5.12-10.41-29.18-
Price-to-Total Gains Ratio36.41-64.50-54.75-128.54-660.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.87296
Number of shares77
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.280.55
Usd Total Gains Per Share0.320.58
Gains per Quarter (77 shares)24.5944.48
Gains per Year (77 shares)98.36177.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
112878810168168
22317418620336346
33526028430504524
44634738240672702
55843448050839880
6695215786010071058
7816086767011751236
8936947748013431414
91047818729015111592
1011686897010016791770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%77.01.00.098.7%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%37.03.00.092.5%66.012.00.084.6%
Dividend per Share3.00.01.075.0%11.00.01.091.7%15.00.05.075.0%25.00.015.062.5%33.00.045.042.3%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%38.02.00.095.0%69.09.00.088.5%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Vitrolife

About Vitrolife AB

Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; Americas; and Asia. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.

Fundamental data was last updated by Penke on 2023-09-22 00:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Vitrolife AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vitrolife earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • A Net Profit Margin of 11.7% means that kr0.12 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vitrolife AB:

  • The MRQ is 11.7%. The company is making a huge profit. +2
  • The TTM is 11.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.7%TTM11.4%+0.3%
TTM11.4%YOY14.7%-3.3%
TTM11.4%5Y20.0%-8.6%
5Y20.0%10Y21.5%-1.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7%-13.5%+25.2%
TTM11.4%-14.9%+26.3%
YOY14.7%-14.7%+29.4%
5Y20.0%-19.2%+39.2%
10Y21.5%-22.5%+44.0%
1.1.2. Return on Assets

Shows how efficient Vitrolife is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • 0.5% Return on Assets means that Vitrolife generated kr0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vitrolife AB:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.5%+0.0%
TTM0.5%YOY0.7%-0.3%
TTM0.5%5Y2.7%-2.2%
5Y2.7%10Y3.6%-0.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%-4.4%+4.9%
TTM0.5%-4.2%+4.7%
YOY0.7%-3.5%+4.2%
5Y2.7%-3.8%+6.5%
10Y3.6%-4.5%+8.1%
1.1.3. Return on Equity

Shows how efficient Vitrolife is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • 0.6% Return on Equity means Vitrolife generated kr0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vitrolife AB:

  • The MRQ is 0.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.6%+0.0%
TTM0.6%YOY0.8%-0.3%
TTM0.6%5Y3.2%-2.6%
5Y3.2%10Y4.5%-1.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%-4.7%+5.3%
TTM0.6%-5.2%+5.8%
YOY0.8%-3.8%+4.6%
5Y3.2%-5.4%+8.6%
10Y4.5%-6.6%+11.1%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Vitrolife AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vitrolife is operating .

  • Measures how much profit Vitrolife makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • An Operating Margin of 20.8% means the company generated kr0.21  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vitrolife AB:

  • The MRQ is 20.8%. The company is operating efficient. +1
  • The TTM is 15.7%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ20.8%TTM15.7%+5.1%
TTM15.7%YOY24.2%-8.6%
TTM15.7%5Y27.2%-11.5%
5Y27.2%10Y19.4%+7.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ20.8%-27.4%+48.2%
TTM15.7%-12.4%+28.1%
YOY24.2%-13.2%+37.4%
5Y27.2%-18.6%+45.8%
10Y19.4%-20.6%+40.0%
1.2.2. Operating Ratio

Measures how efficient Vitrolife is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are kr0.79 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vitrolife AB:

  • The MRQ is 0.793. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.803. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.793TTM0.803-0.009
TTM0.803YOY0.800+0.003
TTM0.8035Y0.732+0.071
5Y0.73210Y0.722+0.010
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7931.425-0.632
TTM0.8031.501-0.698
YOY0.8001.491-0.691
5Y0.7321.461-0.729
10Y0.7221.393-0.671
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Vitrolife AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vitrolife is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.79 means the company has kr2.79 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vitrolife AB:

  • The MRQ is 2.790. The company is able to pay all its short-term debts. +1
  • The TTM is 2.549. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.790TTM2.549+0.241
TTM2.549YOY6.545-3.996
TTM2.5495Y5.674-3.125
5Y5.67410Y4.437+1.238
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7902.785+0.005
TTM2.5493.001-0.452
YOY6.5453.857+2.688
5Y5.6743.651+2.023
10Y4.4373.577+0.860
1.3.2. Quick Ratio

Measures if Vitrolife is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • A Quick Ratio of 2.10 means the company can pay off kr2.10 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vitrolife AB:

  • The MRQ is 2.100. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.792. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.100TTM1.792+0.307
TTM1.792YOY5.935-4.143
TTM1.7925Y4.676-2.884
5Y4.67610Y3.495+1.181
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1001.601+0.499
TTM1.7921.703+0.089
YOY5.9352.404+3.531
5Y4.6762.304+2.372
10Y3.4952.300+1.195
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Vitrolife AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vitrolife assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vitrolife to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.18 means that Vitrolife assets are financed with 18.3% credit (debt) and the remaining percentage (100% - 18.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vitrolife AB:

  • The MRQ is 0.183. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.184. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.183TTM0.184-0.001
TTM0.184YOY0.168+0.017
TTM0.1845Y0.157+0.027
5Y0.15710Y0.189-0.032
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1830.408-0.225
TTM0.1840.378-0.194
YOY0.1680.342-0.174
5Y0.1570.442-0.285
10Y0.1890.464-0.275
1.4.2. Debt to Equity Ratio

Measures if Vitrolife is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • A Debt to Equity ratio of 22.5% means that company has kr0.22 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vitrolife AB:

  • The MRQ is 0.225. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.226. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.225TTM0.226-0.002
TTM0.226YOY0.208+0.018
TTM0.2265Y0.188+0.038
5Y0.18810Y0.242-0.054
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2250.571-0.346
TTM0.2260.532-0.306
YOY0.2080.474-0.266
5Y0.1880.618-0.430
10Y0.2420.684-0.442
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Vitrolife AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Vitrolife generates.

  • Above 15 is considered overpriced but always compare Vitrolife to the Medical Devices industry mean.
  • A PE ratio of 66.89 means the investor is paying kr66.89 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vitrolife AB:

  • The EOD is 45.490. Based on the earnings, the company is overpriced. -1
  • The MRQ is 66.893. Based on the earnings, the company is expensive. -2
  • The TTM is 68.705. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD45.490MRQ66.893-21.403
MRQ66.893TTM68.705-1.812
TTM68.705YOY230.272-161.567
TTM68.7055Y131.377-62.672
5Y131.37710Y173.644-42.267
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD45.490-1.218+46.708
MRQ66.893-1.473+68.366
TTM68.705-1.685+70.390
YOY230.272-3.199+233.471
5Y131.377-2.769+134.146
10Y173.644-2.378+176.022
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vitrolife AB:

  • The EOD is 22.853. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 33.605. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 36.013. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD22.853MRQ33.605-10.752
MRQ33.605TTM36.013-2.408
TTM36.013YOY0.378+35.635
TTM36.0135Y67.783-31.770
5Y67.78310Y170.764-102.981
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD22.853-2.976+25.829
MRQ33.605-3.991+37.596
TTM36.013-4.975+40.988
YOY0.378-6.532+6.910
5Y67.783-6.826+74.609
10Y170.764-6.574+177.338
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vitrolife is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.60 means the investor is paying kr1.60 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Vitrolife AB:

  • The EOD is 1.091. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.604. Based on the equity, the company is underpriced. +1
  • The TTM is 1.534. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.091MRQ1.604-0.513
MRQ1.604TTM1.534+0.070
TTM1.534YOY5.120-3.586
TTM1.5345Y10.406-8.872
5Y10.40610Y29.177-18.771
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.0912.139-1.048
MRQ1.6042.694-1.090
TTM1.5342.671-1.137
YOY5.1203.743+1.377
5Y10.4063.984+6.422
10Y29.1774.378+24.799
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Vitrolife AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.9023.117+57%25.543-81%6.030-19%3.209+53%
Book Value Per Share--130.523125.208+4%97.176+34%52.502+149%29.295+346%
Current Ratio--2.7902.549+9%6.545-57%5.674-51%4.437-37%
Debt To Asset Ratio--0.1830.184-1%0.168+9%0.157+17%0.189-3%
Debt To Equity Ratio--0.2250.226-1%0.208+8%0.188+19%0.242-7%
Dividend Per Share--0.8490.415+104%0.404+110%0.361+135%0.278+206%
Eps--0.7830.716+9%0.644+22%0.653+20%0.498+57%
Free Cash Flow Per Share--1.5581.360+15%0.582+168%0.736+112%0.549+184%
Free Cash Flow To Equity Per Share--0.5610.556+1%10.664-95%2.438-77%1.335-58%
Gross Profit Margin---0.651-0.712+9%-0.533-18%-0.175-73%-0.033-95%
Intrinsic Value_10Y_max--95.252--------
Intrinsic Value_10Y_min--36.460--------
Intrinsic Value_1Y_max--4.690--------
Intrinsic Value_1Y_min--2.461--------
Intrinsic Value_3Y_max--17.791--------
Intrinsic Value_3Y_min--8.471--------
Intrinsic Value_5Y_max--35.353--------
Intrinsic Value_5Y_min--15.615--------
Market Cap19287653939.200-47%28362603475.20026066776689.600+9%53115544187.200-47%32453848075.344-13%37089251030.128-24%
Net Profit Margin--0.1170.114+3%0.147-20%0.200-41%0.215-45%
Operating Margin--0.2080.157+33%0.242-14%0.272-24%0.194+7%
Operating Ratio--0.7930.803-1%0.800-1%0.732+8%0.722+10%
Pb Ratio1.091-47%1.6041.534+5%5.120-69%10.406-85%29.177-95%
Pe Ratio45.490-47%66.89368.705-3%230.272-71%131.377-49%173.644-61%
Price Per Share142.400-47%209.400192.450+9%392.150-47%239.606-13%273.829-24%
Price To Free Cash Flow Ratio22.853-47%33.60536.013-7%0.378+8785%67.783-50%170.764-80%
Price To Total Gains Ratio24.760-47%36.40964.499-44%54.751-34%128.537-72%660.197-94%
Quick Ratio--2.1001.792+17%5.935-65%4.676-55%3.495-40%
Return On Assets--0.0050.005+5%0.007-33%0.027-82%0.036-86%
Return On Equity--0.0060.006+5%0.008-29%0.032-81%0.045-87%
Total Gains Per Share--5.7513.533+63%25.948-78%6.390-10%3.487+65%
Usd Book Value--1598181600.0001533093600.000+4%1189866405.600+34%642855675.640+149%358703491.340+346%
Usd Book Value Change Per Share--0.4430.282+57%2.309-81%0.545-19%0.290+53%
Usd Book Value Per Share--11.79911.319+4%8.785+34%4.746+149%2.648+346%
Usd Dividend Per Share--0.0770.038+104%0.037+110%0.033+135%0.025+206%
Usd Eps--0.0710.065+9%0.058+22%0.059+20%0.045+57%
Usd Free Cash Flow--19074400.00016656200.000+15%7122096.200+168%9008671.880+112%6728090.060+184%
Usd Free Cash Flow Per Share--0.1410.123+15%0.053+168%0.067+112%0.050+184%
Usd Free Cash Flow To Equity Per Share--0.0510.050+1%0.964-95%0.220-77%0.121-58%
Usd Market Cap1743603916.104-47%2563979354.1582356436612.740+9%4801645194.523-47%2933827866.011-13%3352868293.124-24%
Usd Price Per Share12.873-47%18.93017.397+9%35.450-47%21.660-13%24.754-24%
Usd Profit--9582400.0008768800.000+9%7886563.800+22%7998894.840+20%6098729.780+57%
Usd Revenue--81812000.00077111200.000+6%56518012.200+45%45216407.600+81%31455143.300+160%
Usd Total Gains Per Share--0.5200.319+63%2.346-78%0.578-10%0.315+65%
 EOD+4 -4MRQTTM+33 -3YOY+16 -205Y+16 -2010Y+23 -13

3.2. Fundamental Score

Let's check the fundamental score of Vitrolife AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1545.490
Price to Book Ratio (EOD)Between0-11.091
Net Profit Margin (MRQ)Greater than00.117
Operating Margin (MRQ)Greater than00.208
Quick Ratio (MRQ)Greater than12.100
Current Ratio (MRQ)Greater than12.790
Debt to Asset Ratio (MRQ)Less than10.183
Debt to Equity Ratio (MRQ)Less than10.225
Return on Equity (MRQ)Greater than0.150.006
Return on Assets (MRQ)Greater than0.050.005
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.404
Ma 20Greater thanMa 50142.085
Ma 50Greater thanMa 100150.470
Ma 100Greater thanMa 200182.944
OpenGreater thanClose140.900
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets21,648,000
Total Liabilities3,969,000
Total Stockholder Equity17,677,000
 As reported
Total Liabilities 3,969,000
Total Stockholder Equity+ 17,677,000
Total Assets = 21,648,000

Assets

Total Assets21,648,000
Total Current Assets1,816,000
Long-term Assets1,816,000
Total Current Assets
Cash And Cash Equivalents 687,000
Net Receivables 680,000
Inventory 450,000
Other Current Assets -1,000
Total Current Assets  (as reported)1,816,000
Total Current Assets  (calculated)1,816,000
+/-0
Long-term Assets
Property Plant Equipment 349,000
Goodwill 14,552,000
Intangible Assets 4,755,000
Other Assets 129,000
Long-term Assets  (as reported)19,832,000
Long-term Assets  (calculated)19,785,000
+/- 47,000

Liabilities & Shareholders' Equity

Total Current Liabilities651,000
Long-term Liabilities3,318,000
Total Stockholder Equity17,677,000
Total Current Liabilities
Short-term Debt 149,000
Short Long Term Debt 113,000
Accounts payable 224,000
Other Current Liabilities 53,000
Total Current Liabilities  (as reported)651,000
Total Current Liabilities  (calculated)539,000
+/- 112,000
Long-term Liabilities
Long term Debt Total 2,125,000
Long term Debt 2,050,000
Capital Lease Obligations Min Short Term Debt-38,000
Long-term Liabilities Other 13,000
Long-term Liabilities  (as reported)3,318,000
Long-term Liabilities  (calculated)4,150,000
+/- 832,000
Total Stockholder Equity
Common Stock28,000
Retained Earnings 2,096,000
Capital Surplus 13,544,000
Total Stockholder Equity (as reported)17,677,000
Total Stockholder Equity (calculated)15,668,000
+/- 2,009,000
Other
Capital Stock28,000
Cash And Equivalents687,000
Cash and Short Term Investments 687,000
Common Stock Shares Outstanding 135,395
Current Deferred Revenue225,000
Liabilities and Stockholders Equity 21,648,000
Net Debt 1,587,000
Net Invested Capital 19,840,000
Net Working Capital 1,165,000
Short Long Term Debt Total 2,274,000



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-06-30
> Total Assets 
116,790
312,222
328,042
292,784
188,515
158,754
183,995
193,055
193,661
192,714
185,538
193,369
205,990
206,727
211,370
280,024
276,381
281,880
271,034
285,361
291,012
295,811
299,460
306,758
317,817
323,243
342,662
351,868
342,141
339,523
359,315
374,309
389,393
388,251
429,388
436,471
442,136
463,004
466,780
473,881
501,471
495,293
462,198
465,841
479,565
467,236
487,808
497,442
505,265
554,346
972,482
960,446
957,279
993,135
1,059,243
1,107,151
1,128,830
1,189,371
1,250,491
1,286,096
1,302,928
1,317,216
1,422,424
1,550,134
1,566,360
1,619,292
1,697,467
1,880,172
1,952,673
2,092,341
2,138,687
2,247,569
2,203,185
2,255,316
2,305,089
2,497,494
2,513,722
6,140,833
19,428,796
19,535,000
19,907,000
20,206,000
20,551,000
20,762,000
21,648,000
21,648,00020,762,00020,551,00020,206,00019,907,00019,535,00019,428,7966,140,8332,513,7222,497,4942,305,0892,255,3162,203,1852,247,5692,138,6872,092,3411,952,6731,880,1721,697,4671,619,2921,566,3601,550,1341,422,4241,317,2161,302,9281,286,0961,250,4911,189,3711,128,8301,107,1511,059,243993,135957,279960,446972,482554,346505,265497,442487,808467,236479,565465,841462,198495,293501,471473,881466,780463,004442,136436,471429,388388,251389,393374,309359,315339,523342,141351,868342,662323,243317,817306,758299,460295,811291,012285,361271,034281,880276,381280,024211,370206,727205,990193,369185,538192,714193,661193,055183,995158,754188,515292,784328,042312,222116,790
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,818
0
115,751
118,378
131,563
137,267
133,610
144,556
153,436
164,696
242,131
249,369
142,816
155,863
161,969
161,664
187,325
203,255
213,122
260,255
308,782
301,490
314,634
354,566
414,454
466,823
340,605
397,477
476,519
532,647
562,887
604,247
709,905
757,817
777,613
849,720
850,576
956,480
918,350
1,069,634
1,150,224
1,237,464
1,239,973
1,310,340
1,414,442
1,593,101
1,623,547
5,252,743
1,406,601
1,409,000
1,328,000
1,408,000
1,572,000
1,653,000
1,816,000
1,816,0001,653,0001,572,0001,408,0001,328,0001,409,0001,406,6015,252,7431,623,5471,593,1011,414,4421,310,3401,239,9731,237,4641,150,2241,069,634918,350956,480850,576849,720777,613757,817709,905604,247562,887532,647476,519397,477340,605466,823414,454354,566314,634301,490308,782260,255213,122203,255187,325161,664161,969155,863142,816249,369242,131164,696153,436144,556133,610137,267131,563118,378115,7510103,818000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,987
0
11,344
9,608
18,617
17,811
10,408
15,516
20,873
26,764
19,115
15,018
11,680
19,309
18,824
30,997
53,769
65,514
70,805
119,274
107,598
90,458
75,648
115,902
199,572
202,333
75,971
118,651
189,245
218,078
235,739
285,055
395,963
399,289
421,397
496,225
490,810
522,078
446,548
599,010
689,538
715,478
753,796
834,256
973,566
1,117,594
1,155,482
4,763,324
630,094
583,000
444,000
461,000
578,000
618,000
687,000
687,000618,000578,000461,000444,000583,000630,0944,763,3241,155,4821,117,594973,566834,256753,796715,478689,538599,010446,548522,078490,810496,225421,397399,289395,963285,055235,739218,078189,245118,65175,971202,333199,572115,90275,64890,458107,598119,27470,80565,51453,76930,99718,82419,30911,68015,01819,11526,76420,87315,51610,40817,81118,6179,60811,344015,987000000000000000000000000000000
       Net Receivables 
18,495
22,871
24,601
25,159
23,055
21,086
13,424
19,615
19,185
18,325
13,244
22,796
24,732
18,669
15,697
32,379
31,671
30,945
28,090
38,151
33,998
33,184
27,410
41,334
43,764
43,657
38,655
52,705
54,071
48,300
38,768
53,593
52,128
48,857
42,830
64,584
67,072
68,637
57,291
68,670
64,164
67,533
58,361
72,457
78,850
67,485
67,275
76,193
81,566
77,858
102,166
112,719
132,999
127,093
104,045
157,780
140,679
143,992
133,514
160,841
178,186
173,145
153,614
194,970
184,818
186,025
189,231
231,637
253,668
242,412
240,179
274,530
218,978
236,751
226,295
248,319
227,707
239,138
391,000
414,000
459,000
433,000
454,000
618,000
680,000
680,000618,000454,000433,000459,000414,000391,000239,138227,707248,319226,295236,751218,978274,530240,179242,412253,668231,637189,231186,025184,818194,970153,614173,145178,186160,841133,514143,992140,679157,780104,045127,093132,999112,719102,16677,85881,56676,19367,27567,48578,85072,45758,36167,53364,16468,67057,29168,63767,07264,58442,83048,85752,12853,59338,76848,30054,07152,70538,65543,65743,76441,33427,41033,18433,99838,15128,09030,94531,67132,37915,69718,66924,73222,79613,24418,32519,18519,61513,42421,08623,05525,15924,60122,87118,495
       Other Current Assets 
0
0
2,399
0
1,466
0
1,534
0
0
0
3,046
0
0
0
3,092
0
0
0
4,199
0
0
0
3,215
0
0
0
6,098
0
0
532
45,984
4,788
56,573
53,941
56,336
67,021
67,383
68,637
66,854
69,438
159,855
171,694
68,727
74,104
78,850
67,485
73,640
76,193
81,566
77,858
109,508
112,719
133,318
127,093
112,598
158,170
140,679
143,992
141,620
160,841
178,186
173,145
163,386
204,142
198,844
196,557
198,580
257,022
282,584
264,225
251,866
287,459
234,810
251,772
236,849
260,630
243,429
253,681
463,613
490,000
-1,000
1,000
0
-1,000
-1,000
-1,000-1,00001,000-1,000490,000463,613253,681243,429260,630236,849251,772234,810287,459251,866264,225282,584257,022198,580196,557198,844204,142163,386173,145178,186160,841141,620143,992140,679158,170112,598127,093133,318112,719109,50877,85881,56676,19373,64067,48578,85074,10468,727171,694159,85569,43866,85468,63767,38367,02156,33653,94156,5734,78845,984532006,0980003,2150004,1990003,0920003,0460001,53401,46602,39900
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255,497
0
273,642
269,873
297,825
299,204
308,526
318,448
313,344
309,185
259,340
245,924
319,382
309,978
317,596
305,572
300,483
294,187
292,143
294,091
663,700
658,956
642,645
638,569
644,789
640,328
788,225
791,894
773,972
753,449
740,041
712,969
712,519
792,317
788,747
769,572
846,891
923,692
1,034,323
1,022,707
988,463
1,010,105
963,212
944,976
890,648
904,393
890,177
888,090
18,022,195
18,126,000
18,579,000
18,798,000
18,978,000
19,109,000
19,832,000
19,832,00019,109,00018,978,00018,798,00018,579,00018,126,00018,022,195888,090890,177904,393890,648944,976963,2121,010,105988,4631,022,7071,034,323923,692846,891769,572788,747792,317712,519712,969740,041753,449773,972791,894788,225640,328644,789638,569642,645658,956663,700294,091292,143294,187300,483305,572317,596309,978319,382245,924259,340309,185313,344318,448308,526299,204297,825269,873273,6420255,497000000000000000000000000000000
       Property Plant Equipment 
36,185
67,666
106,370
136,887
94,155
88,979
77,385
81,716
84,425
86,828
83,656
89,721
97,276
88,527
88,802
88,860
85,328
83,677
81,736
82,612
81,333
77,444
76,639
72,137
76,114
86,610
94,802
103,389
98,763
92,990
93,038
91,531
94,142
86,598
91,316
95,209
95,304
97,519
95,444
92,520
101,019
95,957
94,445
93,873
93,005
87,172
85,956
83,878
84,214
85,366
92,322
95,776
91,697
90,271
89,641
87,681
90,533
90,536
93,655
91,517
89,672
84,895
84,432
86,427
91,246
90,440
94,127
174,598
176,168
180,580
173,358
175,747
164,025
154,079
142,113
146,759
160,441
159,451
332,974
347,000
359,000
342,000
318,000
307,000
349,000
349,000307,000318,000342,000359,000347,000332,974159,451160,441146,759142,113154,079164,025175,747173,358180,580176,168174,59894,12790,44091,24686,42784,43284,89589,67291,51793,65590,53690,53387,68189,64190,27191,69795,77692,32285,36684,21483,87885,95687,17293,00593,87394,44595,957101,01992,52095,44497,51995,30495,20991,31686,59894,14291,53193,03892,99098,763103,38994,80286,61076,11472,13776,63977,44481,33382,61281,73683,67785,32888,86088,80288,52797,27689,72183,65686,82884,42581,71677,38588,97994,155136,887106,37067,66636,185
       Goodwill 
0
0
22,001
0
4,741
0
4,011
0
3,646
3,464
3,282
4,011
4,011
4,011
4,011
83,265
83,265
83,265
83,265
83,265
83,265
83,265
83,265
87,542
87,542
88,250
88,250
89,294
89,294
89,294
97,301
97,301
97,301
97,301
120,289
118,221
118,355
120,736
120,771
119,584
120,952
114,995
182,114
175,586
182,670
180,105
183,275
180,969
183,789
185,400
364,545
364,835
358,394
364,252
350,474
351,793
394,052
402,128
403,216
402,393
404,806
399,718
408,937
422,562
424,994
421,583
421,610
427,790
430,915
435,619
425,841
442,311
422,241
421,413
403,239
411,717
409,736
411,441
12,994,620
13,111,000
13,461,000
13,696,000
13,874,000
14,025,000
14,552,000
14,552,00014,025,00013,874,00013,696,00013,461,00013,111,00012,994,620411,441409,736411,717403,239421,413422,241442,311425,841435,619430,915427,790421,610421,583424,994422,562408,937399,718404,806402,393403,216402,128394,052351,793350,474364,252358,394364,835364,545185,400183,789180,969183,275180,105182,670175,586182,114114,995120,952119,584120,771120,736118,355118,221120,28997,30197,30197,30197,30189,29489,29489,29488,25088,25087,54287,54283,26583,26583,26583,26583,26583,26583,26583,2654,0114,0114,0114,0113,2823,4643,64604,01104,741022,00100
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,948
8,917
9,162
9,100
9,168
12,706
13,611
18,387
23,602
26,118
30,774
32,414
32,674
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000032,67432,41430,77426,11823,60218,38713,61112,7069,1689,1009,1628,9178,9480000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
25,712
25,527
26,010
30,278
7,841
12,238
6,480
12,160
3,646
3,464
6,563
13,777
15,190
23,429
7,805
110,966
110,838
110,020
92,243
108,210
108,266
107,712
91,569
110,797
111,107
113,242
96,924
117,978
117,734
119,721
105,176
136,803
48,163
54,417
65,323
68,358
76,681
204,005
131,461
205,330
144,634
21,316
33,892
32,376
40,760
37,058
22,982
19,176
18,368
17,136
196,846
187,339
181,957
175,556
165,044
161,926
266,288
261,432
245,871
231,768
221,415
204,929
198,801
264,339
254,046
238,500
306,387
293,777
382,119
371,280
352,417
352,931
329,079
319,669
299,480
295,615
281,676
268,808
4,552,903
4,536,000
4,609,000
4,635,000
4,648,000
4,629,000
4,755,000
4,755,0004,629,0004,648,0004,635,0004,609,0004,536,0004,552,903268,808281,676295,615299,480319,669329,079352,931352,417371,280382,119293,777306,387238,500254,046264,339198,801204,929221,415231,768245,871261,432266,288161,926165,044175,556181,957187,339196,84617,13618,36819,17622,98237,05840,76032,37633,89221,316144,634205,330131,461204,00576,68168,35865,32354,41748,163136,803105,176119,721117,734117,97896,924113,242111,107110,79791,569107,712108,266108,21092,243110,020110,838110,9667,80523,42915,19013,7776,5633,4643,64612,1606,48012,2387,84130,27826,01025,52725,712
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,036
31,557
2,565
17,416
18,186
16,924
2,318
11,335
13,687
13,656
3,210
3,225
1,161
1,237
5,444
5,548
5,772
6,189
9,987
11,006
10,597
8,490
9,666
9,371
8,106
8,122
8,948
8,917
9,162
9,100
9,168
12,706
13,611
18,387
23,601
26,118
30,774
32,414
32,674
35,024
43,273
44,814
39,461
40,184
27,202
31,267
49,226
49,000
50,000
36,000
36,000
39,000
1,000
1,00039,00036,00036,00050,00049,00049,22631,26727,20240,18439,46144,81443,27335,02432,67432,41430,77426,11823,60118,38713,61112,7069,1689,1009,1628,9178,9488,1228,1069,3719,6668,49010,59711,0069,9876,1895,7725,5485,4441,2371,1613,2253,21013,65613,68711,3352,31816,92418,18617,4162,56531,55734,03600000000000000000000000000000000
> Total Liabilities 
29,940
52,648
86,301
70,961
76,070
60,111
40,560
41,649
39,528
36,823
34,964
32,574
36,917
34,428
34,920
63,728
60,232
59,986
50,395
52,720
49,903
50,368
46,076
49,692
54,173
50,258
50,274
47,672
44,237
40,872
47,246
48,699
57,129
60,475
103,055
110,932
119,260
122,762
122,877
123,823
144,491
523,516
183,216
179,948
186,867
162,468
165,208
155,332
162,006
170,096
269,911
218,618
220,079
192,178
214,271
222,555
233,056
233,124
230,107
209,265
213,468
176,507
193,775
218,738
221,269
208,358
201,255
282,941
349,328
364,709
341,059
320,958
315,638
294,616
288,075
333,539
362,780
364,747
4,087,926
3,993,000
3,917,000
3,804,000
3,811,000
3,747,000
3,969,000
3,969,0003,747,0003,811,0003,804,0003,917,0003,993,0004,087,926364,747362,780333,539288,075294,616315,638320,958341,059364,709349,328282,941201,255208,358221,269218,738193,775176,507213,468209,265230,107233,124233,056222,555214,271192,178220,079218,618269,911170,096162,006155,332165,208162,468186,867179,948183,216523,516144,491123,823122,877122,762119,260110,932103,05560,47557,12948,69947,24640,87244,23747,67250,27450,25854,17349,69246,07650,36849,90352,72050,39559,98660,23263,72834,92034,42836,91732,57434,96436,82339,52841,64940,56060,11176,07070,96186,30152,64829,940
   > Total Current Liabilities 
29,940
32,648
44,299
40,551
49,176
38,531
20,994
21,591
19,594
17,363
18,873
15,869
20,228
17,881
19,368
24,591
22,823
23,209
28,574
31,880
31,351
33,396
31,340
36,493
50,334
45,745
46,952
43,389
41,482
39,084
40,053
41,826
51,302
55,451
71,284
76,232
88,083
91,182
61,332
71,060
90,539
474,286
80,168
92,663
111,730
95,280
99,724
100,565
106,353
118,278
159,831
135,093
143,723
126,426
131,396
139,800
124,881
128,385
159,318
141,295
147,575
116,316
134,895
130,401
132,617
120,702
152,275
163,862
191,770
223,092
202,352
180,523
181,878
169,054
177,014
220,844
240,548
245,494
954,326
918,000
748,000
670,000
621,000
596,000
651,000
651,000596,000621,000670,000748,000918,000954,326245,494240,548220,844177,014169,054181,878180,523202,352223,092191,770163,862152,275120,702132,617130,401134,895116,316147,575141,295159,318128,385124,881139,800131,396126,426143,723135,093159,831118,278106,353100,56599,72495,280111,73092,66380,168474,28690,53971,06061,33291,18288,08376,23271,28455,45151,30241,82640,05339,08441,48243,38946,95245,74550,33436,49331,34033,39631,35131,88028,57423,20922,82324,59119,36817,88120,22815,86918,87317,36319,59421,59120,99438,53149,17640,55144,29932,64829,940
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,981
0
10,389
13,012
20,406
29,393
37,947
40,589
5,424
10,653
12,413
399,034
16,825
16,826
17,219
15,526
17,028
16,820
17,166
16,385
25,774
20,060
19,243
12,235
11,876
12,002
12,319
12,601
37,390
34,207
31,518
79
81
85
0
0
0
10,683
13,131
14,175
14,632
15,409
15,147
14,440
13,593
13,302
15,948
15,675
455,673
474,000
305,000
199,000
182,000
148,000
149,000
149,000148,000182,000199,000305,000474,000455,67315,67515,94813,30213,59314,44015,14715,40914,63214,17513,13110,68300085817931,51834,20737,39012,60112,31912,00211,87612,23519,24320,06025,77416,38517,16616,82017,02815,52617,21916,82616,825399,03412,41310,6535,42440,58937,94729,39320,40613,01210,38902,981000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,856
34,653
31,950
79
81
85
0
0
0
29,033
33,635
31,072
0
0
0
0
0
0
0
0
428,610
442,000
273,000
169,000
153,000
119,000
113,000
113,000119,000153,000169,000273,000442,000428,6100000000031,07233,63529,03300085817931,95034,65337,8560000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
11,523
0
9,615
0
6,399
0
0
6,563
8,680
5,846
8,635
6,855
7,263
8,931
6,167
8,023
9,170
10,989
9,521
12,372
9,505
10,963
16,817
14,207
23,531
14,544
11,523
13,075
14,697
15,149
16,274
19,642
26,643
19,286
17,380
18,206
19,865
23,743
21,258
18,464
17,444
20,815
16,788
12,030
15,596
17,567
11,106
19,444
22,282
20,436
20,415
17,668
21,749
22,785
21,806
23,272
24,286
24,609
24,274
27,793
30,598
24,876
28,195
26,483
32,085
40,039
36,088
40,517
29,314
30,934
38,850
23,848
25,922
47,601
46,901
45,079
173,081
179,000
187,000
201,000
181,000
174,000
224,000
224,000174,000181,000201,000187,000179,000173,08145,07946,90147,60125,92223,84838,85030,93429,31440,51736,08840,03932,08526,48328,19524,87630,59827,79324,27424,60924,28623,27221,80622,78521,74917,66820,41520,43622,28219,44411,10617,56715,59612,03016,78820,81517,44418,46421,25823,74319,86518,20617,38019,28626,64319,64216,27415,14914,69713,07511,52314,54423,53114,20716,81710,9639,50512,3729,52110,9899,1708,0236,1678,9317,2636,8558,6355,8468,6806,563006,39909,615011,52300
       Other Current Liabilities 
0
0
17,265
0
33,211
0
13,200
0
0
9,405
7,948
7,650
9,003
8,447
9,461
11,016
12,012
10,542
12,851
14,338
15,277
14,471
15,396
19,091
21,658
20,679
20,204
26,628
27,742
22,376
22,375
23,696
24,639
22,797
24,235
27,553
32,756
32,387
36,043
36,664
56,868
56,788
45,899
55,022
77,723
67,724
67,100
66,178
78,081
82,449
111,775
94,597
104,065
96,523
97,771
105,013
90,756
92,512
97,642
82,479
91,783
88,444
104,216
105,440
104,422
94,219
120,190
113,140
142,551
168,400
158,406
134,180
127,881
130,766
137,499
159,941
177,699
146,094
299,083
265,000
256,000
270,000
258,000
274,000
53,000
53,000274,000258,000270,000256,000265,000299,083146,094177,699159,941137,499130,766127,881134,180158,406168,400142,551113,140120,19094,219104,422105,440104,21688,44491,78382,47997,64292,51290,756105,01397,77196,523104,06594,597111,77582,44978,08166,17867,10067,72477,72355,02245,89956,78856,86836,66436,04332,38732,75627,55324,23522,79724,63923,69622,37522,37627,74226,62820,20420,67921,65819,09115,39614,47115,27714,33812,85110,54212,01211,0169,4618,4479,0037,6507,9489,4050013,200033,211017,26500
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,193
0
5,827
5,024
31,771
34,700
31,177
31,580
61,545
52,763
53,952
49,230
103,048
87,285
75,137
67,188
65,484
54,767
55,653
51,818
110,080
83,525
76,356
65,752
82,875
82,755
108,175
104,739
70,789
67,970
65,893
60,191
58,880
88,337
88,652
87,656
48,980
119,079
157,558
141,617
138,707
140,435
133,760
125,562
111,061
112,695
122,232
119,253
3,133,600
3,075,000
3,169,000
3,134,000
3,190,000
3,151,000
3,318,000
3,318,0003,151,0003,190,0003,134,0003,169,0003,075,0003,133,600119,253122,232112,695111,061125,562133,760140,435138,707141,617157,558119,07948,98087,65688,65288,33758,88060,19165,89367,97070,789104,739108,17582,75582,87565,75276,35683,525110,08051,81855,65354,76765,48467,18875,13787,285103,04849,23053,95252,76361,54531,58031,17734,70031,7715,0245,82707,193000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,181
48,810
46,743
55,880
52,609
2,026,821
1,983,000
2,038,000
2,009,000
2,043,000
2,007,000
2,125,000
2,125,0002,007,0002,043,0002,009,0002,038,0001,983,0002,026,82152,60955,88046,74348,81052,1810000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
543
543
0
0
0
0
0
0
0
0
1
0
0
0
2,489
0
0
0
2,285
0
0
0
0
0
850
850
33,735
24,465
27,277
36,590
29,192
22,917
23,872
24,144
23,791
6,303
5,529
5,205
5,191
10,188
9,140
8,395
9,043
9,012
10,302
7,214
7,311
37,120
88,652
87,656
48,980
52,887
91,376
77,280
77,494
81,148
77,869
73,381
62,251
65,952
66,352
66,644
1,106,779
1,092,000
1,131,000
1,125,000
0
0
0
0001,125,0001,131,0001,092,0001,106,77966,64466,35265,95262,25173,38177,86981,14877,49477,28091,37652,88748,98087,65688,65237,1207,3117,21410,3029,0129,0438,3959,14010,1885,1915,2055,5296,30323,79124,14423,87222,91729,19236,59027,27724,46533,735850850000002,2850002,4890001000000005435430000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,999
0
0
0
51,772
0
0
0
41,905
0
0
0
36,524
0
0
0
34,111
0
0
0
58,436
0
0
0
0
0
0
00000058,43600034,11100036,52400041,90500051,77200066,9990000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
86,850
259,574
241,741
221,823
111,400
97,742
143,435
151,406
154,133
155,891
150,574
160,795
169,073
172,299
176,450
216,296
216,149
221,894
220,639
232,641
241,109
245,443
253,384
256,654
263,122
272,469
292,061
303,882
297,475
298,200
311,588
325,007
331,572
327,075
325,676
324,755
321,961
339,278
342,970
349,022
355,858
-29,362
277,791
284,610
291,205
303,198
320,956
340,299
341,694
382,631
700,914
739,970
735,133
798,764
843,151
882,486
893,818
954,117
1,018,055
1,074,054
1,087,045
1,138,129
1,225,857
1,327,995
1,341,974
1,407,781
1,492,914
1,593,568
1,600,108
1,724,250
1,794,023
1,922,499
1,883,653
1,956,346
2,012,570
2,158,713
2,146,647
5,771,466
15,322,175
15,529,000
15,977,000
16,386,000
16,736,000
17,013,000
17,677,000
17,677,00017,013,00016,736,00016,386,00015,977,00015,529,00015,322,1755,771,4662,146,6472,158,7132,012,5701,956,3461,883,6531,922,4991,794,0231,724,2501,600,1081,593,5681,492,9141,407,7811,341,9741,327,9951,225,8571,138,1291,087,0451,074,0541,018,055954,117893,818882,486843,151798,764735,133739,970700,914382,631341,694340,299320,956303,198291,205284,610277,791-29,362355,858349,022342,970339,278321,961324,755325,676327,075331,572325,007311,588298,200297,475303,882292,061272,469263,122256,654253,384245,443241,109232,641220,639221,894216,149216,296176,450172,299169,073160,795150,574155,891154,133151,406143,43597,742111,400221,823241,741259,57486,850
   Common Stock
0
0
18,390
0
18,390
0
18,390
0
0
0
18,390
0
0
0
18,390
216,296
216,149
221,894
19,790
232,641
241,109
245,443
19,800
256,654
263,122
272,469
19,800
19,800
19,944
19,944
19,944
19,944
19,944
19,944
19,944
19,951
19,954
19,954
19,954
19,954
355,007
19,954
20,228
20,228
20,228
20,228
20,228
20,228
20,228
20,228
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
24,112
27,631
27,000
28,000
28,000
28,000
28,000
28,000
28,00028,00028,00028,00028,00027,00027,63124,11222,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14420,22820,22820,22820,22820,22820,22820,22820,22819,954355,00719,95419,95419,95419,95419,95119,94419,94419,94419,94419,94419,94419,94419,80019,800272,469263,122256,65419,800245,443241,109232,64119,790221,894216,149216,29618,39000018,39000018,390018,390018,39000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
494,610
494,610
494,610
483,763
494,610
494,610
494,610
4,025,886
13,543,973
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,00013,544,00013,544,00013,544,00013,544,00013,544,00013,543,9734,025,886494,610494,610494,610483,763494,610494,610494,6100000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
190,181
0
0
0
185,116
0
0
0
185,254
0
0
0
183,348
0
0
0
182,138
0
0
0
477,972
0
0
0
469,929
0
0
0
506,569
8,754
6,894
-6,782
507,177
43,344
58,378
49,118
544,864
65,590
69,764
87,200
555,456
604,096
553,625
537,420
496,534
523,731
17,318
4,051,406
13,564,557
13,714,000
14,138,000
16,386,000
14,708,000
14,885,000
15,553,000
15,553,00014,885,00014,708,00016,386,00014,138,00013,714,00013,564,5574,051,40617,318523,731496,534537,420553,625604,096555,45687,20069,76465,590544,86449,11858,37843,344507,177-6,7826,8948,754506,569000469,929000477,972000182,138000183,348000185,254000185,116000190,181000000000000000000000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.